Perfusion Extracorporeal Technology

Gembloux ·KBO/BCE: BE 0784.827.493

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	nothing on record	not filed	-
31-12-2024	31-07-2025	20-08-2025	20 d late	2025-00390394
31-12-2023	31-07-2024	24-07-2024	7 d early	2024-00283402
31-12-2022	31-07-2023	29-08-2023	29 d late	2023-00430816

Metric	This company	Sector median	Position in the sector
Solvency	51.6%	25.2%	better than 70% of 3355 sector peers
Net result	€2k	€4k	better than 46% of 3342 sector peers
Equity	€15k	€23k	better than 45% of 3362 sector peers
Gross operating margin	€7k	€19k	better than 38% of 3328 sector peers
Total assets	€30k	€105k	better than 20% of 3360 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€30k
Fixed assets	21/28	€2k
Tangible fixed assets	22/27	€2k
Current assets	29/58	€27k
Amounts receivable within one year	40/41	€16k
Cash & bank	54/58	€7k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€30k
Equity	10/15	€15k
Contributions / capital	10/11	€2k
Accumulated profits (losses)	14	€13k
Amounts payable	17/49	€14k
Amounts payable within one year	42/48	€14k
Trade debts payable within one year	44	€4k
Income statement
Gross operating margin	9900	€7k
Operating result	9901	€5k
Financial income	75	€6
Financial charges	65	€895
Result before taxes	9903	€4k
Income taxes	67/77	€2k
Net result for the period	9904	€2k
Result to be appropriated	9905	€2k

Summary

Legal nameFR	Perfusion Extracorporeal Technology
AbbreviationFR	PEx Tech